Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study)

Published:2017-05-02 Issue:7 Volume:24 Page:525-531
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Yamanishi Tomonori¹,Asakura Hirotaka²,Seki Narihito³,Tokunaga Shoji⁴

Affiliation:

1. Department of Urology; Continence Center; Dokkyo Medical University; Mibu Tochigi Japan

2. Department of Urology; Saitama Medical University Hospital; Saitama Japan

3. Department of Urology; Kyushu Central Hospital; Fukuoka Japan

4. Medical Information Center; Kyushu University Hospital; Fukuoka Japan

Funder

Kyorin Pharmaceutical

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13359/fullpdf

Reference22 articles.

1. Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract;Engström;BJU Int.,2005

2. Clinical efficacy and safety of imidafenacin as add-on treatment for persistent overactive bladder symptoms despite α-blocker treatment in patients with BPH: the ADDITION study;Takeda;Urology,2013

3. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with α-blockers;Chapple;Eur. Urol.,2009

4. Safety and tolerability of solifenacin add-on therapy to α-blocker treated men with residual urgency and frequency;Kaplan;J. Urol.,2009

5. The International Continence Society “Benign Prostatic Hyperplasia” Study: the bothersomeness of urinary symptoms;Peters;J. Urol.,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age‐specific effect of transurethral holmium laser enucleation of the prostate on overactive bladder in men with benign prostatic hyperplasia: An investigation using an overactive bladder symptom score;LUTS: Lower Urinary Tract Symptoms;2022-12-11

2. Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients;Asian Journal of Urology;2022-01

3. Triple Therapy with Tamsulosin, Dutasteride, and Imidafenacin for Benign Prostatic Hyperplasia in Patients with Overactive Bladder Symptoms Refractory to Tamsulosin: Subgroup Analyses of the DIrecT Study;Urologia Internationalis;2021

4. The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigens (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis;Central European Journal of Urology;2021

5. Meta-Analysis of the Efficacy and Safety of Imidafenacin for Overactive Bladder Induced by Benign Prostatic Hyperplasia in Men Receiving Alpha-Blocker Therapy;International Neurourology Journal;2020-12-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3